Key result
Circulating microRNAs accurately detect viral myocarditis with a pooled AUC of ~0.90.
Why the study?
Current diagnostic tools for viral myocarditis present significant limitations, and the diagnostic and prognostic role of microRNAs needed evaluation.
Do circulating miRNAs provide accurate diagnostic and prognostic value for viral myocarditis in human subjects?
Meta-Analysis
Do circulating miRNAs provide accurate diagnostic and prognostic value for viral myocarditis in human subjects?
Circulating miRNAs show promising diagnostic accuracy for viral myocarditis with a pooled AUC of 0.897, though substantial heterogeneity and methodological limitations necessitate further prospective validation.
Answers are grounded in this paper and cite their sources.
Circulating miRNAs may aid viral myocarditis diagnosis; leaves open routine clinical adoption pending prospective validation.
Background Current diagnostic tools for viral myocarditis (VM) present significant limitations. Recent studies have shown that microRNAs (miRNAs) are promising circulating biomarkers. The aim of this meta-analysis is to evaluate the diagnostic and prognostic role of miRNAs in VM. Methods A systematic literature search was conducted across five databases (PubMed, Scopus, Embase, Google Scholar, and the Cochrane Library). Eligible studies reported miRNA diagnostic and/or prognostic accuracy in human subjects with VM diagnosis. Methodological quality of the included studies was assessed using the QUADAS-2 tool. Pooled estimates of area under the curve (AUC), sensitivity, specificity, and summary receiver operating characteristic (SROC) curves were calculated. Results A total of 26 studies were included in our analysis; 42 differentially expressed miRNAs were identified; 30 exhibited upregulated expression, 9 demonstrated downregulation, and 3 had variable expression patterns. The pooled diagnostic AUC for VM was 0.897 (0.863–0.931; I 2 = 93.4%); bivariate analysis yielded a pooled sensitivity of 0.758 (0.582–0.876; I 2 = 87.1%) and specificity of 0.881 (0.811–0.928; I 2 = 78.5%). Regarding fulminant myocarditis (FM) detection, the pooled AUC was 0.883 (95% CI: 0.837–0.930; I 2 = 87.3%). Conclusions Circulating miRNAs represent promising candidate biomarkers for the diagnosis of VM, although the available evidence remains preliminary. Further large-scale prospective studies are needed to reproduce and validate these results.
No takes yet. Share an insight, caveat, or question.
Holst et al. (2026) conducted a meta-analysis in Viral myocarditis. Circulating microRNAs vs. Healthy controls or other myocardial conditions was evaluated on Diagnostic accuracy for viral myocarditis (pooled AUC) (AUC 0.897, 95% CI 0.863-0.931). Circulating microRNAs demonstrated high diagnostic accuracy for viral myocarditis, yielding a pooled area under the curve of 0.897, a sensitivity of 0.758, and a specificity of 0.881.
Synapse has enriched 10 related papers. Consider them for comparative context: